MYLAN LABS LTD FDA Approval ANDA 204927

ANDA 204927

MYLAN LABS LTD

FDA Drug Application

Application #204927

Application Sponsors

ANDA 204927MYLAN LABS LTD

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION20MG/ML0ETOPOSIDEETOPOSIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-10-31

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

MYLAN LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204927
            [companyName] => MYLAN LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"ETOPOSIDE","activeIngredients":"ETOPOSIDE","strength":"20MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/31\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-10-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.